HOTARARE Nr. 516 din 8 mai 2003
privind modificarea si completarea Hotararii Guvernului nr. 1.417/2002 pentru
aprobarea Listei cuprinzand medicamentele de care beneficiaza asiguratii in
tratamentul ambulatoriu, cu sau fara contributie personala, pe baza de
prescriptie medicala, in sistemul de asigurari sociale de sanatate
ACT EMIS DE: GUVERNUL ROMANIEI
ACT PUBLICAT IN: MONITORUL OFICIAL NR. 321 din 13 mai 2003
In temeiul art. 107 din Constitutie,
Guvernul Romaniei adopta prezenta hotarare.
ARTICOL UNIC
Anexele nr. 1 si 2 la Hotararea Guvernului nr. 1.417/2002 pentru aprobarea
Listei cuprinzand medicamentele de care beneficiaza asiguratii in tratamentul
ambulatoriu, cu sau fara contributie personala, pe baza de prescriptie
medicala, in sistemul de asigurari sociale de sanatate, publicata in Monitorul
Oficial al Romaniei, Partea I, nr. 927 din 18 decembrie 2002, se inlocuiesc cu
anexele nr. 1 si 2*) care fac parte integranta din prezenta hotarare.
------------
*) Anexele nr. 1 si 2 sunt reproduse in facsimil.
PRIM-MINISTRU
ADRIAN NASTASE
Contrasemneaza:
Ministrul sanatatii si familiei,
Daniela Bartos
Presedintele Casei Nationale
de Asigurari de Sanatate,
Eugeniu Turlea
ANEXA 1
LISTA DENUMIRILOR COMUNE INTERNATIONALE ALE PRODUSELOR MEDICAMENTOASE DE
CARE BENEFICIAZA ASIGURATII, IN AMBULATORIU FARA CONTRIBUTIE PERSONALA
Sectiunea A - Medicamente de baza, optiune terapeutica 1
1. INSUFICIENTA CARDIACA CRONICA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 1.| 1.| C01A A05 | Digoxinum
|
|____|____|__________|_________________________________________________________|
| 2.| 2.| C03A A03 | Hydrochlorothiazidum
|
|____|____|__________|_________________________________________________________|
| 3.| 3.| C09A A01 | Captoprilum
|
|____|____|__________|_________________________________________________________|
| 4.| 4.| C09A A02 | Enalaprilum |
|____|____|__________|_________________________________________________________|
| 5.| 5.| C03C A01 | Furosemidum
|
|____|____|__________|_________________________________________________________|
| 6.| 6.| C03D A01 | Spironolactonum
|
|____|____|__________|_________________________________________________________|
2. BOLNAVI CU PROTEZE VALVULARE SI VASCULARE
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 7.| 1.| B01A A07 | Acenocoumarolum
|
|____|____|__________|_________________________________________________________|
| 8.| 2.| B01A C06 | Acidum acetylsalicylicum cp. cu concentratie pana la
|
| | | | 100 mg
|
|____|____|__________|_________________________________________________________|
3. ACCIDENT VASCULAR CEREBRAL POSTACUT (inclusiv atacul vascular cerebral
tranzitoriu)
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC | |
|____|____|__________|_________________________________________________________|
| 9.| 1.| B01A A07 | Acenocoumarolum
|
|____|____|__________|_________________________________________________________|
| 10.| 2.| B01A C06 | Acidum acetylsalicylicum cp. cu concentratie pana la
|
| | | | 100 mg
|
|____|____|__________|_________________________________________________________|
4. HEPATITA VIRALA ACUTA (cu HAV, HBV, HCV sau HGV), hepatitele cronice de
etiologie virala (cu markeri de replicare virala pozitivi).
5. CIROZA HEPATICA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 11.| 1.| A05A A02 | Acidum ursodeoxycholicum
|
|____|____|__________|_________________________________________________________|
| 12.| 2.| A06A D11 | Lactulosum
|
|____|____|__________|_________________________________________________________|
| 13.| 3.| C03C A01 | Furosemidum
|
|____|____|__________|_________________________________________________________|
| 14.| 4.| C03D A01 | Spironolactonum |
|____|____|__________|_________________________________________________________|
| 15.| 5.| C07A A05 | Propranololum
|
|____|____|__________|_________________________________________________________|
| 16.| 6.| H02A B07 | Prednisonum
|
|____|____|__________|_________________________________________________________|
| 17.| 7.| J01C A01 | Ampicillinum
|
|____|____|__________|_________________________________________________________|
| 18.| 8.| J01M A06 | Norfloxacinum
|
|____|____|__________|_________________________________________________________|
| 19.| 9.| J05A F05 | Lamivudinum
|
|____|____|__________|_________________________________________________________|
| 20.| 9.| L04A X01 | Azatioprinum
|
|____|____|__________|_________________________________________________________|
| 21.| 10.| V03A C01 | Deferoxaminum
|
|____|____|__________|_________________________________________________________|
6. HIV/SIDA
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National HIV/SIDA.
7. TALASEMIE
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 22.| 1.| V03A C01 | Deferoxaminum |
|____|____|__________|_________________________________________________________|
8. LEUCEMII, LIMFOAME SI APLAZIE MEDULARA TUMORI MALIGNE
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 23.| 1.| A03F A01 | Metoclopramidum
|
|____|____|__________|_________________________________________________________|
| 24.| 2.| A04A A01 | Ondansetronum
|
|____|____|__________|_________________________________________________________|
| 25.| 3.| H02A B02 | Dexamethasonum
|
|____|____|__________|_________________________________________________________|
| 26.| 4.| N02A A01 | Morphinum |
|____|____|__________|_________________________________________________________|
| 27.| 5.| N02A A08 | Dihydrocodeinum
|
|____|____|__________|_________________________________________________________|
| 28.| 6.| N02A B02 | Pethidinum
|
|____|____|__________|_________________________________________________________|
| 29.| 7.| N02A X02 | Tramadolum |
|____|____|__________|_________________________________________________________|
| 30.| 8.| N02A A03 | Hydromorphonum
|
|____|____|__________|_________________________________________________________|
| 31.| 9.| N05A N01 | Lithii carbonas
|
|____|____|__________|_________________________________________________________|
| 32.| 10.| N07B C02 | Methadonum
|
|____|____|__________|_________________________________________________________|
| 33.| 11.| R05D A04 | Codeinum
|
|____|____|__________|_________________________________________________________|
NOTA:
Medicamentele (D.C.I.) aferente grupei "Leucemii, limfoame si aplazie
medulara" sunt listate impreuna cu cele corespunzatoare grupei
"Tumori maligne" datorita faptului ca un numar mare de produse sunt
comune celor doua grupe.
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National de Cancer.
9. EPILEPSIE
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I. |
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 34.| 1.| N03A A02 | Phenobarbitalum
|
|____|____|__________|_________________________________________________________|
| 35.| 2.| N03A B02 | Phenitoinum
|
|____|____|__________|_________________________________________________________|
| 36.| 3.| N03A D01 | Ethosuximidum
|
|____|____|__________|_________________________________________________________|
| 37.| 4.| N03A E01 | Clonazepamum
|
|____|____|__________|_________________________________________________________|
| 38.| 5.| N03A F01 | Carbamazepinum
|
|____|____|__________|_________________________________________________________|
| 39.| 6.| N03A G01 | Acidum valproicum si saruri
|
|____|____|__________|_________________________________________________________|
| 40.| 7.| N03A X09 | Lamotriginum
|
|____|____|__________|_________________________________________________________|
| 41.| 8.| N03A X11 | Topiramatum
|
|____|____|__________|_________________________________________________________|
10. BOALA PARKINSON
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 42.| 1.| N04A A01 | Trihexyphenidilum
|
|____|____|__________|_________________________________________________________|
| 43.| 2.| N04A A02 | Biperidenum |
|____|____|__________|_________________________________________________________|
| 44.| 3.| N04B A02 | Levodopum + Carbidopum
|
|____|____|__________|_________________________________________________________|
| 45.| 4.| N04B A02 | Levodopum + Benserazidum
|
|____|____|__________|_________________________________________________________|
| 46.| 5.| N04B C04 | Ropinirolum*)
|
|____|____|__________|_________________________________________________________|
| 47.| 6.| N04B C05 | Pramipexolum*)
|
|____|____|__________|_________________________________________________________|
| 48.| 7.| N04B D01 | Selegilinum
|
|____|____|__________|_________________________________________________________|
*) Numai cu avizul comisiilor din institutele de specialitate sau din
centrele universitare.
11. MIOPATII (MIOPATIILE INFLAMATORII)
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC | |
|____|____|__________|_________________________________________________________|
| 49.| 1.| H02A B07 | Prednisonum
|
|____|____|__________|_________________________________________________________|
| 50.| 2.| L01A A01 | Cyclophosphamidum
|
|____|____|__________|_________________________________________________________|
12. MIASTENIA GRAVIS
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 51.| 1.| H02A B07 | Prednisonum
|
|____|____|__________|_________________________________________________________|
| 52.| 2.| N07A A01 | Neostigmini bromidum
|
|____|____|__________|_________________________________________________________|
| 53.| 3.| N07A A02 | Piridostigminum
|
|____|____|__________|_________________________________________________________|
13. SCLEROZA MULTIPLA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 54.| 1.| H02A B04 | Methylprednisolonum
|
|____|____|__________|_________________________________________________________|
| 55.| 2.| H02A B07 | Prednisonum |
|____|____|__________|_________________________________________________________|
| 56.| 3.| L03A B07 | Interferonum Beta 1a*)
|
|____|____|__________|_________________________________________________________|
| 57.| 4.| L03A B08 | Interferonum Beta 1b*)
|
|____|____|__________|_________________________________________________________|
| 58.| 5.| L03A X13 | Glatiramer acetat*) |
|____|____|__________|_________________________________________________________|
*) Se prescriu numai pentru pacientii inclusi in subprogramul
<<Preventie si diagnostic precoce in bolile neurologice>>.
14. BOLI PSIHICE (Schizofrenie, tulburari schizotipale si delirante,
tulburari afective, psihoze toxice si infectioase, tulburari psihotice acute,
dementele degenerative de tip Alzheimer, vasculare si mixte)
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 59.| 1.| N03A G01 | Acidum valproicum si saruri
|
|____|____|__________|_________________________________________________________|
| 60.| 2.| N04A A01 | Trihexyphenidilum
|
|____|____|__________|_________________________________________________________|
| 61.| 3.| N05A D01 | Haloperidolum
|
|____|____|__________|_________________________________________________________|
| 62.| 4.| N05A F01 | Flupentixolum
|
|____|____|__________|_________________________________________________________|
| 63.| 5.| N05A H02 | Clozapinum
|
|____|____|__________|_________________________________________________________|
| 64.| 6.| N05A L05 | Amisulpridum
|
|____|____|__________|_________________________________________________________|
| 65.| 7.| N05A N01 | Lithii carbonas |
|____|____|__________|_________________________________________________________|
| 66.| 8.| N06A A04 | Clomipraminum
|
|____|____|__________|_________________________________________________________|
| 67.| 9.| N06A A09 | Amitriptylinum
|
|____|____|__________|_________________________________________________________|
| 68.| 10.| N06A A12 | Doxepinum
|
|____|____|__________|_________________________________________________________|
| 69.| 11.| N06A A21 | Maprotilinum
|
|____|____|__________|_________________________________________________________|
| 70.| 12.| N06A X03 | Mianserinum
|
|____|____|__________|_________________________________________________________|
| 71.| 13.| N06D A02 | Donepezilum*)
|
|____|____|__________|_________________________________________________________|
| 72.| 14.| N06D A03 | Rivastigminum*)
|
|____|____|__________|_________________________________________________________|
*) Vor fi prescrise numai cu avizul comisiei terapeutice de la nivelul
spitalului sau al comisiilor de specialitate din centrele universitare.
15. LUPUS ERITEMATOS SISTEMIC
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 73.| 1.| H02A B07 | Prednisonum |
|____|____|__________|_________________________________________________________|
| 74.| 2.| L04A X01 | Azathioprinum
|
|____|____|__________|_________________________________________________________|
| 75.| 3.| P01B A02 | Hydroxicloroquinum
|
|____|____|__________|_________________________________________________________|
16. POLIARTRITA REUMATOIDA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 76.| 1.| A07E C01 | Sulphasalazinum
|
|____|____|__________|_________________________________________________________|
| 77.| 2.| H02A B01 | Bethamethazonum |
|____|____|__________|_________________________________________________________|
| 78.| 3.| H02A B07 | Prednisonum
|
|____|____|__________|_________________________________________________________|
| 79.| 4.| L01B A01 | Methotrexatum
|
|____|____|__________|_________________________________________________________|
| 80.| 5.| M01A B01 | Indometacinum
|
|____|____|__________|_________________________________________________________|
| 81.| 6.| M01A B05 | Diclofenacum
|
|____|____|__________|_________________________________________________________|
| 82.| 7.| M01A C01 | Piroxicamum
|
|____|____|__________|_________________________________________________________|
| 83.| 8.| M01A E03 | Ketoprofenum
|
|____|____|__________|_________________________________________________________|
17. SPONDILITA ANKILOPOETICA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 84.| 1.| A07E C01 | Sulphasalazinum
|
|____|____|__________|_________________________________________________________|
| 85.| 2.| H02A B01 | Bethamethazonum
|
|____|____|__________|_________________________________________________________|
| 86.| 3.| M01A B05 | Diclofenacum |
|____|____|__________|_________________________________________________________|
| 87.| 4.| M01A C01 | Piroxicamum
|
|____|____|__________|_________________________________________________________|
| 88.| 5.| M01A X17 | Nimesulidum
|
|____|____|__________|_________________________________________________________|
18. CHISTUL HIDATIC
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 89.| 1.| P02B A01 | Praziquantelum
|
|____|____|__________|_________________________________________________________|
| 90.| 2.| P02C A03 | Albendazolum |
|____|____|__________|_________________________________________________________|
19. MALARIE
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I. |
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 91.| 1.| P01B A02 | Hydroxicloroquinum
|
|____|____|__________|_________________________________________________________|
20. TUBERCULOZA, MICOBACTERIOZELE ATIPICE SI MUCOVISCIDOZA*)
*) Pentru mucoviscidoza se indica antibioterapie in functie de
susceptibilitatea bacteriana, medicatie mucolitica, bronhodilatatoare si
corticoizi.
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National de TBC.
21. TUMORI MALIGNE
Medicamentele aferente grupei "Tumori maligne" sunt incluse in
grupa "Leucemii, limfoame si aplazia medulara".
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National de Cancer.
22. DIABET ZAHARAT SI BOLI DE NUTRITIE
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National de Diabet si Boli de
Nutritie.
23. BOLI ENDOCRINE (Gusa endemica, boala Addison, diabetul insipid,
mixedemul adultului)
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 92.| 1.| H02A A02 | Fludrocortizonum
|
|____|____|__________|_________________________________________________________|
| 93.| 2.| H02A B09 | Hydrocortizonum |
|____|____|__________|_________________________________________________________|
| 94.| 3.| H02A D07 | Prednisonum
|
|____|____|__________|_________________________________________________________|
| 95.| 4.| H03A A01 | Levothyroxinum
|
|____|____|__________|_________________________________________________________|
| 96.| 5.| H01B A02 | Desmopressinum |
|____|____|__________|_________________________________________________________|
| 97.| 6.| H03C A | Iodidum
|
|____|____|__________|_________________________________________________________|
| 98.| 7.| H03C A01 | Kalii iodidum
|
|____|____|__________|_________________________________________________________|
24. BOALA WILLSON
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 99.| 1.| M01C C01 | Penicillaminum
|
|____|____|__________|_________________________________________________________|
25. STARI POST TRANSPLANT
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
|100.| 1.| A05A A02 | Acidum ursodeoxycholicum
|
|____|____|__________|_________________________________________________________|
|101.| 2.| H02A B04 | Methylprednisolonum
|
|____|____|__________|_________________________________________________________|
|102.| 3.| H02A B07 | Prednisonum
|
|____|____|__________|_________________________________________________________|
|103.| 4.| J01E E01 | Sulphamethoxazolum + Trimethoprimum
|
|____|____|__________|_________________________________________________________|
|104.| 5.| J02A C01 | Fluconazolum
|
|____|____|__________|_________________________________________________________|
|105.| 6.| J05A F05 | Lamivudinum
|
|____|____|__________|_________________________________________________________|
|106.| 7.| L04A A01 | Ciclosporinum |
|____|____|__________|_________________________________________________________|
|107.| 8.| L04A X01 | Azathioprinum
|
|____|____|__________|_________________________________________________________|
Se vor prescrie la recomandarea Centrului care a efectuat transplantul
pentru pacientii inclusi in subprogramul <<Transplant de organe si
tesuturi>>.
26. INSUFICIENTA RENALA CRONICA
27. GLAUCOM
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
|108.| 1.| S01E B01 | Pilocarpinum
|
|____|____|__________|_________________________________________________________|
|109.| 2.| S01E C01 | Acetazolamidum |
|____|____|__________|_________________________________________________________|
|110.| 3.| S01E D01 | Timololum
|
|____|____|__________|_________________________________________________________|
|111.| 4.| S01E D05 | Carteololum
|
|____|____|__________|_________________________________________________________|
|112.| 5.| S01E X03 | Latanoprostum
|
|____|____|__________|_________________________________________________________|
28. BOLI VENERICE [Sifilis, gonoree, infectia cu Clamidia*)]
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
|113.| 1.| J01A A02 | Doxycyclinum |
|____|____|__________|_________________________________________________________|
|114.| 2.| J01A A07 | Tetracyclinum
|
|____|____|__________|_________________________________________________________|
|115.| 3.| J01C E01 | Benzylpenicillinum
|
|____|____|__________|_________________________________________________________|
|116.| 4.| J01C E08 | Benzathini benzylpenicillinum
|
|____|____|__________|_________________________________________________________|
|117.| 5.| J01C E09 | Benzylpenicillinum procainicum
|
|____|____|__________|_________________________________________________________|
|118.| 6.| J01F A01 | Erythromicinum
|
|____|____|__________|_________________________________________________________|
|119.| 7.| J01F A07 | Josamycinum
|
|____|____|__________|_________________________________________________________|
|120.| 8.| J01M A01 | Ofloxacinum
|
|____|____|__________|_________________________________________________________|
*) Confirmata de laborator
29. PEMFIGUS
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
|121.| 1.| H01A A02 | Tetracosactidum
|
|____|____|__________|_________________________________________________________|
|122.| 2.| H02A B02 | Dexamethazonum
|
|____|____|__________|_________________________________________________________|
|123.| 3.| H02A B04 | Methylprednisolonum
|
|____|____|__________|_________________________________________________________|
|124.| 4.| H02A B06 | Prednisolonum
|
|____|____|__________|_________________________________________________________|
|125.| 5.| H02A B07 | Prednisonum |
|____|____|__________|_________________________________________________________|
|126.| 6.| H02A B08 | Triamcinolonum
|
|____|____|__________|_________________________________________________________|
|127.| 7.| H02A B09 | Hydrocortizonum
|
|____|____|__________|_________________________________________________________|
30. PELAGRA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
|128.| 1.| A11H A01 | Acidum nicotinicum
|
|____|____|__________|_________________________________________________________|
31. BOALA GAUCHER
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
|129.| 1.| A16A B02 | Imiglucerasum*)
|
|____|____|__________|_________________________________________________________|
*) Dupa precizarea diagnosticului de catre Centrul de Boli Genetice -
Cluj-Napoca va putea fi prescris de catre sefii clinicilor universitare de
profil (Endocrinometabolice sau gastroenterologice), sau de catre sefii
sectiilor respective de la nivelul spitalului judetean.
NOTA:
Pentru medicamentele din aceasta sectiune tratamentul se initiaza de
medicul de specialitate, luandu-se in considerare mentiunile cu caracter
special, notate cu asterisc.
Sectiunea B - Medicamente cu restrictie la prescriere - optiunea 2,
avizarea prescriptiei medicale
1. INSUFICIENTA CARDIACA CRONICA
2. BOLNAVI CU PROTEZE VALVULARE SI VASCULARE
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC | |
|____|____|__________|_________________________________________________________|
| 1.| 1.| B01A C04 | Clopidogrelum*)
|
|____|____|__________|_________________________________________________________|
| 2.| 2.| B01A C05 | Ticlopidinum
|
|____|____|__________|_________________________________________________________|
*) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz,
si aprobata de directorul de spital.
3. ACCIDENT VASCULAR CEREBRAL POSTACUT (inclusiv atacul vascular cerebral
tranzitoriu)
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 3.| 1.| B01A B04 | Dalteparinum |
|____|____|__________|_________________________________________________________|
| 4.| 2.| B01A B05 | Enoxaparinum
|
|____|____|__________|_________________________________________________________|
| 5.| 3.| B01A B06 | Nadroparinum
|
|____|____|__________|_________________________________________________________|
| 6.| 4.| B01A B08 | Reviparinum |
|____|____|__________|_________________________________________________________|
| 7.| 5.| B01A B10 | Tinzaparinum
|
|____|____|__________|_________________________________________________________|
| 8.| 6.| B01A C04 | Clopidogrelum*)
|
|____|____|__________|_________________________________________________________|
*) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz,
si aprobata de directorul de spital.
4. HEPATITA VIRALA ACUTA (cu HAV, HBV, HCV sau HGV), hepatitele cronice de
etiologie virala (cu markeri de replicare virala pozitivi).
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 9.| 1.| J05A B04 | Ribavirinum*)
|
|____|____|__________|_________________________________________________________|
| 10.| 2.| J05A F05 | Lamivudinum*)
|
|____|____|__________|_________________________________________________________|
| 11.| 3.| L03A B04 | Interferonum Alfa 2a*)
|
|____|____|__________|_________________________________________________________|
| 12.| 4.| L03A B05 | Interferonum Alfa 2b*) |
|____|____|__________|_________________________________________________________|
| 13.| 5.| L03A B10/| Peginterferonum Alfa*)
|
| | | L03A B11 | |
|____|____|__________|_________________________________________________________|
*) Se vor prescrie cu avizul Comisiilor Institutelor de specialitate sau
din Centrele Universitare si vor fi aprobate de catre Comisia Centrala de la
nivelul Casei Nationale de Asigurari de Sanatate.
5. CIROZA HEPATICA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC | |
|____|____|__________|_________________________________________________________|
| 14.| 1.| A07A A11 | Rifaximinum
|
|____|____|__________|_________________________________________________________|
| 15.| 2.| C03A A03 | Hydrochlorothiazidum
|
|____|____|__________|_________________________________________________________|
| 16.| 3.| H02A B04 | Methylprednisolonum |
|____|____|__________|_________________________________________________________|
| 17.| 4.| J01M A02 | Ciprofloxacinum
|
|____|____|__________|_________________________________________________________|
6. HIV/SIDA
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National HIV/SIDA.
7. TALASEMIE
8. LEUCEMII, LIMFOAME SI APLAZIE MEDULARA
TUMORI MALIGNE
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 18.| 1.| A04A A02 | Granisetronum
|
|____|____|__________|_________________________________________________________|
| 19.| 2.| B03X A01 | Epoetinum
|
|____|____|__________|_________________________________________________________|
| 20.| 3.| H01B A02 | Desmopressinum
|
|____|____|__________|_________________________________________________________|
| 21.| 4.| H03A A01 | Levothyroxinum
|
|____|____|__________|_________________________________________________________|
| 22.| 5.| L01D B02 | Daunorubicinum |
|____|____|__________|_________________________________________________________|
| 23.| 6.| L02B G02 | Formestanum
|
|____|____|__________|_________________________________________________________|
| 24.| 7.| L04A A01 | Ciclosporinum
|
|____|____|__________|_________________________________________________________|
| 25.| 8.| N02A D01 | Pentazocinum
|
|____|____|__________|_________________________________________________________|
| 26.| 9.| N03A F01 | Carbamazepinum
|
|____|____|__________|_________________________________________________________|
NOTA:
Medicamentele (D.C.I.) aferente grupei "Leucemii, limfoame si aplazie
medulara" sunt listate impreuna cu cele corespunzatoare grupei
"Tumori maligne" datorita faptului ca un numar mare de produse sunt
comune celor doua grupe.
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National de Cancer.
9. EPILEPSIE
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 27.| 1.| N03A X12 | Gabapentinum |
|____|____|__________|_________________________________________________________|
10. BOALA PARKINSON
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 28.| 1.| N04B B01 | Amantadinum |
|____|____|__________|_________________________________________________________|
| 29.| 2.| N04B C01 | Bromocriptinum
|
|____|____|__________|_________________________________________________________|
| 30.| 3.| N04B X02 | Entacaponum*)
|
|____|____|__________|_________________________________________________________|
| 31.| 4.| N05A H02 | Clozapinum*) |
|____|____|__________|_________________________________________________________|
*) Se vor prescrie cu avizul Comisiilor Institutelor de specialitate sau
din Centrele Universitare.
*) Parkinsonian cu tulburari psihotice
11. MIOPATII (MIOPATIILE INFLAMATORII)
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 32.| 1.| H02A B02 | Dexametazonum
|
|____|____|__________|_________________________________________________________|
| 33.| 2.| H02A B04 | Methilprednisolonum
|
|____|____|__________|_________________________________________________________|
| 34.| 3.| L01B A01 | Methotrexatum
|
|____|____|__________|_________________________________________________________|
| 35.| 4.| L04A X01 | Azathioprinum
|
|____|____|__________|_________________________________________________________|
| 36.| 5.| P01B A02 | Hydroxicloroquinum |
|____|____|__________|_________________________________________________________|
12. MIASTENIA GRAVIS
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 37.| 1.| H01A A02 | Tetracosactidum |
|____|____|__________|_________________________________________________________|
| 38.| 2.| H02A B02 | Dexamethasonum
|
|____|____|__________|_________________________________________________________|
| 39.| 3.| H02A B04 | Methylprednisolonum
|
|____|____|__________|_________________________________________________________|
| 40.| 4.| L04A X01 | Azathioprinum |
|____|____|__________|_________________________________________________________|
13. SCLEROZA MULTIPLA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I. |
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 41.| 1.| L01B A01 | Methotrexatum |
|____|____|__________|_________________________________________________________|
| 42.| 2.| L04A X01 | Azathioprinum
|
|____|____|__________|_________________________________________________________|
14. BOLI PSIHICE (Schizofrenie, tulburari schizotipale si delirante,
tulburari afective, psihoze toxice si infectioase, tulburari psihotice acute,
dementele degenerative de tip Alzheimer, vasculare si mixte)
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 43.| 1.| N04A A02 | Biperidenum
|
|____|____|__________|_________________________________________________________|
| 44.| 2.| N04B D01 | Selegilinum*) |
|____|____|__________|_________________________________________________________|
| 45.| 3.| N05A X08 | Risperidonum*)
|
|____|____|__________|_________________________________________________________|
| 46.| 4.| N05A F05 | Zuclopentixolum*)
|
|____|____|__________|_________________________________________________________|
| 47.| 5.| N05A H03 | Olanzapinum*)
|
|____|____|__________|_________________________________________________________|
| 48.| 6.| N05A H04 | Quetiapinum*)
|
|____|____|__________|_________________________________________________________|
*) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz,
si aprobata de directorul de spital.
15. LUPUS ERITEMATOS SISTEMIC
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I. |
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 49.| 1.| H02A B04 | Methylprednisolonum |
|____|____|__________|_________________________________________________________|
| 50.| 2.| L01A A01 | Cyclophosphamidum
|
|____|____|__________|_________________________________________________________|
| 51.| 3.| L01B A01 | Methotrexatum*)
|
|____|____|__________|_________________________________________________________|
| 52.| 4.| L04A A01 | Ciclosporinum
|
|____|____|__________|_________________________________________________________|
| 53.| 5.| L04A A06 | Mycophenolatum
|
|____|____|__________|_________________________________________________________|
*) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz,
si aprobata de directorul de spital.
16. POLIARTRITA REUMATOIDA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I. |
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 54.| 1.| H02A B04 | Methylprednisolonum |
|____|____|__________|_________________________________________________________|
| 55.| 2.| L04A A01 | Ciclosporinum
|
|____|____|__________|_________________________________________________________|
| 56.| 3.| L04A A12 | Infliximabum*) |
|____|____|__________|_________________________________________________________|
| 57.| 4.| L04A A13 | Leflunomidum*)
|
|____|____|__________|_________________________________________________________|
| 58.| 5.| L04A X01 | Azathioprinum
|
|____|____|__________|_________________________________________________________|
| 59.| 6.| M01BXN2 | Combinatii: Diclofenacum + Misoprostolum*) |
|____|____|__________|_________________________________________________________|
| 60.| 7.| M01C B01 | Natrii aurothiomalas
|
|____|____|__________|_________________________________________________________|
| 61.| 8.| P01B A02 | Hydroxichloroquinum
|
|____|____|__________|_________________________________________________________|
*) Leflunomidum: contraindicatie sau precautie la cei cu leziuni hepatice
preexistente (EMEA); se administreaza la pacientii cu poliartrita reumatoida
care nu raspund adecvat la metotrexat sau sulfasalazina;
*) Infliximabum: la pacientii cu poliartrita reumatoida severa care nu
raspund adecvat la metotrexat se asociaza infliximabum, cu aprobarea comisiei
centrale de la nivelul Casei Nationale de Asigurari de Sanatate;
*) Se prescrie la pacientii care nu tolereaza celelalte antiinflamatoare
din lista.
17. SPONDILITA ANKILOPOETICA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 62.| 1.| L01B A01 | Methotrexatum
|
|____|____|__________|_________________________________________________________|
| 63.| 2.| M01A C06 | Meloxicamum |
|____|____|__________|_________________________________________________________|
18. CHISTUL HIDATIC
19. MALARIE
20. TUBERCULOZA, MICOBACTERIOZELE ATIPICE SI MUCOVISCIDOZA*)
*) Pentru mucoviscidoza se indica antibioterapie in functie de
susceptibilitatea bacteriana, medicatie mucolitica, bronhodilatatoare si
corticoizi.
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National de TBC
21. TUMORI MALIGNE
Medicamentele aferente grupei "Tumori maligne" sunt incluse in
grupa "Leucemii, limfoame si aplazia medulara"
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National de Cancer.
22. DIABET ZAHARAT SI BOLI DE NUTRITIE
Medicamentele vor fi asigurate prin farmaciile apartinand unitatilor
sanitare, prin care se deruleaza Programul National de Diabet si Boli de
Nutritie.
23. BOLI ENDOCRINE (Gusa endemica, boala Addison, diabetul insipid,
mixedemul adultului)
24. BOALA WILLSON
25. STARI POST TRANSPLANT
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I. |
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 64.| 1.| J05A B01 | Aciclovirum
|
|____|____|__________|_________________________________________________________|
| 65.| 2.| J05A B06 | Ganciclovirum
|
|____|____|__________|_________________________________________________________|
| 66.| 3.| L04A A05 | Tacrolimus
|
|____|____|__________|_________________________________________________________|
| 67.| 4.| L04A A06 | Mycophenolatum
|
|____|____|__________|_________________________________________________________|
| 68.| 5.| L04A A10 | Sirolimus
|
|____|____|__________|_________________________________________________________|
Se vor prescrie cu avizul centrului care a efectuat transplantul, pentru
pacientii inclusi in subprogramul <<Transplant de organe si
tesuturi>>.
26. INSUFICIENTA RENALA CRONICA
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 69.| 1.| A11C C03 | Alfacalcidolum |
|____|____|__________|_________________________________________________________|
| 70.| 2.| B03X A01 | Epoetinum
|
|____|____|__________|_________________________________________________________|
Se prescriu numai pentru pacientii inclusi in subprogramul
<<Preventie in patologia nefrologica si dializa>>.
27. GLAUCOM
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 71.| 1.| S01E C03 | Dorzolamidum
|
|____|____|__________|_________________________________________________________|
| 72.| 2.| S01E C04 | Brinzolamidum
|
|____|____|__________|_________________________________________________________|
| 73.| 3.| S01E D02 | Betaxololum
|
|____|____|__________|_________________________________________________________|
28. BOLI VENERICE [Sifilis, gonoree, infectia cu Clamidia*)]
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 74.| 1.| J01D A06 | Cefuroximum
|
|____|____|__________|_________________________________________________________|
| 75.| 2.| J01D A13 | Ceftriaxonum
|
|____|____|__________|_________________________________________________________|
| 76.| 3.| J01D A39 | Ceftibutenum
|
|____|____|__________|_________________________________________________________|
| 77.| 4.| J01E E01 | Sulfamethoxazolum + Trimethoprimum
|
|____|____|__________|_________________________________________________________|
| 78.| 5.| J01F A10 | Azithromycinum |
|____|____|__________|_________________________________________________________|
| 79.| 6.| J01M A02 | Ciprofloxacinum
|
|____|____|__________|_________________________________________________________|
| 80.| 7.| J01M A06 | Norfloxacinum
|
|____|____|__________|_________________________________________________________|
*) Confirmata de laborator
29. PEMFIGUS
______________________________________________________________________________
|Nr. |Nr. | Grupa | D.C.I.
|
|crt.|crt.| ATC |
|
|____|____|__________|_________________________________________________________|
| 81.| 1.| J04B A02 | Dapsonum
|
|____|____|__________|_________________________________________________________|
| 82.| 2.| L01A A01 | Cyclophosphamidum |
|____|____|__________|_________________________________________________________|
| 83.| 3.| L01B A01 | Methotrexatum
|
|____|____|__________|_________________________________________________________|
| 84.| 4.| L04A A01 | Ciclosporinum*)
|
|____|____|__________|_________________________________________________________|
| 85.| 5.| L04A X01 | Azathioprinum |
|____|____|__________|_________________________________________________________|
*) Prescrierea va fi avizata de seful de sectie si/sau clinica, dupa caz,
si aprobata de directorul de spital.
30. PELAGRA
31. BOALA GAUCHER
NOTA:
Medicamentele cuprinse in aceasta sectiune sunt recomandate si prescrise
numai in una din urmatoarele situatii: cand prin folosirea medicamentelor din
Sectiunea A nu se obtine un raspuns terapeutic adecvat, reactiile adverse sunt
majore, exista contraindicatii datorate unei boli asociate sau cand numai
medicamentele din aceasta Sectiune B reprezinta solutia terapeutica exclusiva.
Tratamentul cu aceste medicamente se initiaza de medicul de specialitate,
luandu-se in considerare mentiunile cu caracter special notate cu asterisc (*).
Prescrierea medicamentelor din aceasta sectiune se va aviza cel putin de
catre comisia terapeutica a spitalului din aceasta sectiune.
ANEXA 2
LISTA DENUMIRILOR COMUNE INTERNATIONALE ALE PRODUSELOR MEDICAMENTOASE DE
CARE BENEFICIAZA ASIGURATII, IN AMBULATORIU CU CONTRIBUTIE PERSONALA
Sectiunea A - Medicamente de baza, optiune terapeutica 1
Nivelul de compensare pentru medicamentele corespunzatoare acestor DCI este
de 65% (*)
1. A02B BISMUTHI SUBCITRAS
2. A02B FAMOTIDINUM
3. A02B LANSOPRAZOLUM
4. A02B OMEPRAZOLUM
5. A02B RANITIDINUM
6. A03A MEBEVERINUM
7. A03B BUTYLSCOPOLAMMONII BROMIDUM
8. A03F METOCLOPRAMIDUM
9. A04A PROCHLORPERAZINUM
10. A07A NYSTATINUM
11. A07D LOPERAMIDUM
12. A07E MESALAZINUM - numai in caz de intoleranta la SULFASALAZINUM*)
13. A07E SULFASALAZINUM*)
14. A11C ALFACALCIDOLUM
15. B01A ACENOCOUMAROLUM*)
16. B02B PHYTOMENADIONUM
17. B03A FERROSII FUMARAS
18. B03A FERROSII GLUTAMAS
19. B03A FERROSII SULFAS
20. C01A DIGOXINUM
21. C01B AMIODARONUM*)
22. C01B CHINIDINI SULFAS*)
23. C01B MEXILETINUM*)
24. C01B PROPAFENONUM*)
25. C01D ISOSORBIDI DINITRAS
26. C01D ISOSORBIDI MONONITRAS
27. C01D NITROGLYCERINUM
28. C01E TRIMETAZIDINUM
29. C02A CLONIDINUM
30. C02C PRAZOSINUM
31. C02A DIHYDRALAZINUM - in combinatii
32. C03A HIDROCHLOROTHIAZIDUM
33. C03B INADAPAMIDUM
34. C03C FUROSEMIDUM
35. C03D SPIRONOLACTONUM
36. C07A ATENOLOLUM
37. C07A BETAXOLOLUM
38. C07A BISOPROLOLUM
39. C07A CARVEDILOLUM
40. C07A METOPROLOLUM
41. C07A NEBIVOLOLUM
42. C07A PROPRANOLOLUM
43. C07A SOTALOLUM - numai ca antiaritmic*)
44. C08C NIFEDIPINUM cu eliberare prelungita
45. C08D DILTIAZEMUM*)
46. C08D VERAPAMILUM*)
47. C09A CAPTOPRILUM
48. C09A ENALAPRILUM
49. C09A FOSINOPRILUM*)
50. C09A LISINOPRILUM*)
51. C09A PERINDOPRILUM*)
52. C09A QUINAPRILUM*)
53. C09A RAMIPRILUM*)
54. C09A BENAZEPRILUM*)
55. C09A TRANDOLAPRILUM*)
56. C10A BEZAFIBRATUM
57. C10A GEMFIBROZILUM
58. C10A FENOFIBRATUM
59. C10A SIMVASTATINUM*)
60. D01A BIFONAZOLUM
61. D01A MICONAZOLUM
62. D01B GRISEOFULVINUM*)
63. D06B PODOPHYLLOTOXINUM*)
64. D07A CLOBETASOLUM
65. D07A FLUMETASONUM
66. D07A HYDROCORTIZONUM
67. D07A TRIAMCINOLONUM ACETONID
68. G02A METHYLERGOMETRINUM*)
69. G02C BROMOCRIPTINUM*)
70. G03A MEDROXYPROGESTERONUM*)
71. G03B TESTOSTERONUM*)
72. G03C ESTRADIOLUM*)
73. G03C ESTRIOLUM*)
74. G03D LYNESTRENOLUM*)
75. G03D PROGESTERONUM*)
76. G03F (G03C) ESTROGENI - simpli si combinatii*)
77. G03G CLOMIFENUM*)
78. G04C DOXAZOSINUM*)
79. G04C TERAZOSINUM*)
80. H02A DEXAMETHASONUM
81. H02A METHYLPREDNISOLONUM*)
82. H02A PREDNISOLONUM
83. H02A PREDNISONUM
84. H03B CARBIMAZOLUM*)
85. H03B THIAMAZOLUM*)
86. J01A DOXYCYCLINUM
87. J01A TETRACYCLINUM
88. J01C AMOXICILLINUM
89. J01C AMPICILLINUM
90. J01C BENZATHINI BENZYLPENICILLINUM
91. J01C BENZYLPENICILLINUM
92. J01C OXACILLINUM
93. J01C PHENOXYMETHYLPENICILLINUM
94. J01D CEFACLORUM
95. J01D CEFALEXINUM (ORAL)
96. J01D CEFUROXIMUM (ORAL)
97. J01E SULFAMETHOXAZOLUM + TRIMETHOPRIMUM
98. J01F ERYTROMYCINUM
99. J01G GENTAMICINUM
100. J01M CIPROFLOXACINUM
101. J01M NORFLOXACINUM
102. J01X METRONIDAZOLUM
103. J01X TINIDAZOLUM
104. J02A FLUCONAZOLUM (ORAL)
105. J02A KETOCONAZOLUM
106. J05A ACICLOVIRUM
107. J01M OFLOXACINUM
108. M01A DICLOFENACUM
109. M01A INDOMETACINUM
110. M01A KETOPROFENUM
111. M01A NIMESULIDUM
112. M01A PIROXICAMUM
113. M01A TENOXICAMUM
114. M03B TETRAZEPAMUM
115. M04A ALLOPURINOLUM*)
116. M04A COLCHICINUM*)
117. N02A TRAMADOLUM
118. N03A CARBAMAZEPINUM
119. N05A CHLORPROMAZINUM
120. N05A THIORIDAZINUM
121. N05B ALPRAZOLAMUM
122. N05B BROMAZEPAMUM
123. N05B DIAZEPAMUM
124. N05B HYDROXYZINUM
125. N05B MEDAZEPAMUM
126. N05B OXAZEPAMUM
127. N05C NITRAZEPAMUM
128. N07C BETAHISTINUM
129. N07X ACIDUM ALFA-LIPOICUM
130. P02B PRAZIQUANTELUM
131. P02C MEBENDAZOLUM
132. P02C ALBENDAZOLUM
133. P02C LEVAMISOLUM
134. R03A SALBUTAMOLUM
135. R03B ACIDUM CROMOGLICICUM
136. R03B BECLOMETHASONUM
137. R03B BUDESONIDUM
138. R03D AMINOPHYLLINUM
139. R03D THEOPHILLINUM
140. R05D CODEINUM
141. R06A CHLORPHENIRAMINUM (CHLORPHENA)
142. R06A KETOTIFENUM
143. R06A LORATADINUM
144. R06A PROMETHAZINUM
145. S01A CIPROFLOXACINUM
146. S01C TOBRAMICINUM + DEXAMETAZONUM
147. S01G ACIDUM CROMOGLICICUM
NOTA:
Tratamentul cu medicamentele notate cu asterisc (*) se initiaza de medicul
de specialitate in limita competentei si poate fi prescris in continuare de
medicul de familie pe baza scrisorii medicale emisa de medicul de specialitate.
Sectiunea B - Medicamente cu restrictie la prescriere optiune terapeutica 2
Nivelul de compensare pentru medicamentele corespunzatoare acestor DCI este
de 50% (*)
1. A02B NIZATIDINUM
2. A02B PANTOPRAZOLUM
3. A02B SUCRALFATUM
4. A03A OTILONIUM BROMIDUM
5. A03A TRIMEBUTINUM
6. A03F DOMPERIDONUM
7. A11C COLECALCIFEROLUM
8. B01A CLOPIDOGRELUM - pentru pacientii cu intoleranta la aspirina
9. B01A SULODEXIDUM
10. B01A TICLOPIDINUM - pentru pacientii cu intoleranta la aspirina
11. B03A COMPLEX DE HIDROXID DE FIER (III)
12. C02A METHYLDOPUM
13. C02A MOXONIDINUM
14. C04A CODERGOCRINUM
15. C04A NICERGOLINUM
16. C04A PENTOXIFYLLINUM
17. C04A VINCAMINUM
18. C05C DIOSMINUM - simplu si in combinatii
19. C08C AMLODIPINUM
20. C08C FELODIPINUM
21. C08C LERCANIDIPINUM
22. C09C CANDESARTANUM
23. C09C IRBESARTANUM
24. C09C LOZARTANUM
25. C09C TELMISARTANUM
26. C09C VALSARTANUM
27. C10A ATORVASTATINUM
28. C10A CIPROFIBRATUM
29. C10A FLUVASTATINUM
30. C10A PRAVASTATINUM
31. D01A NAFTIFINUM
32. D01A NATAMYCINUM
33. D01B TERBINAFINUM
34. D05A CALCIPOTRIOLUM
35. D06A MUPIROCINUM
36. D06B SULFADIAZINUM
37. D07A METHYLPREDNISOLONUM
38. D07X MOMETASONUM
39. D10A ACIDUM AZELAICUM
40. D10B ISOTRETINOINUM
41. G01A FENTICONAZOLUM
42. G03C HEXESTROLUM
43. G03C PROMESTRIENUM
44. G03D DYDROGESTERONUM
45. G03X RALOXIFENUM
46. G04B EMEPRONII BROMIDUM
47. G04B OXYBUTYNINUM
48. G04C ALFUZOSINUM
49. G04C FINASTERIDUM
50. G04C TAMSULOSINUM
51. H01A TETRACOSACTIDUM
52. H02A BETAMETHASONUM
53. H02A FLUDROCORTISONUM
54. H02A HYDROCORTISONUM
55. H05B CALCITONINUM
56. J01C AMOXICILLINUM + ACIDUM CLAVULANICUM
57. J01C SULTAMICILLINUM
58. J01D CEFTIBUTENUM (ORAL)
59. J01F AZITHROMICINUM
60. J01F CLARITHROMYCINUM
61. J01F CLINDAMYCINUM
62. J02A ITRACONAZOLUM
63. M01A CELECOXIBUM
64. M01A MELOXICAMUM
65. M01A ROFECOXIBUM
66. M03B BACLOFENUM
67. M05B ACIDUM ALENDRONICUM
68. M05B ACIDUM PAMIDRONICUM
69. N02C SUMATRIPTANUM
70. N02C RIZATRIPTANUM
71. N05A SULPIRIDUM
72. N05A TIAPRIDUM
73. N05C ZOLPIDEMUM
74. N05C ZOPICLONUM
75. N06A FLUVOXAMINUM
76. N06A MILNACIPRANUM
77. N06A MIRTAZAPINUM
78. N06A PAROXETINUM
79. N06A REBOXETINUM
80. N06A SERTRALINUM
81. N06A TIANEPTINUM
82. N06A VENLAFAXINUM
83. N06A FLUOXETINUM
84. N06B PRAMIRACETAMUM
85. N06B VINPOCETINUM
86. N06D GINKGO BILOBA (extract standardizat conform Pharmacopeei]
87. N07X HIDROLIZAT DE PROTEINA DIN CREIER DE PORCINA
88. P01B HYDROXYCHLOROQUINUM
89. R03A FENOTEROLUM
90. R03A SALMETEROLUM
91. R03A SALMETEROLUM + FLUTICASONUM
92. R03A TERBUTALINUM
93. R03B FLUTICASONUM
94. R03B IPRATROPII BROMIDUM
95. R03D MONTELUKAST
96. R05D DEXTROMETHORPHANUM
97. R05D LEVODROPROPIZINUM
98. R06A FEXOFENADINUM
99. R06A DESLORATADINUM
100. R06A THIETHYLPERAZINUM
101. S01G EMEDASTINUM
NOTA:
Medicamentele cuprinse in aceasta sectiune sunt recomandate si prescrise
numai in una din urmatoarele situatii: cand prin folosirea medicamentelor din
Sectiunea A nu se obtine un raspuns terapeutic adecvat, reactiile adverse sunt
majore, exista contraindicatii datorate unei boli asociate sau cand numai
medicamentele din aceasta Sectiune B reprezinta solutia terapeutica exclusiva.
Medicamentele vor fi prescrise de medicul de specialitate; prescrierea
poate fi continuata conform schemei terapeutice de tratament prescrisa de
medicul de specialitate si de catre medicul de familie.
(*) Cota procentuala de 65%, respectiv 50%, se aplica la pretul cel mai mic
corespunzator unitatii terapeutice aferente aceleiasi forme farmaceutice, din cadrul
aceleiasi denumiri comune internationale si pentru fiecare concentratie.
Valoarea astfel rezultata reprezinta pretul de referinta.